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Available online 5 June 2012AbstractThe first evidence that a mononucleotide difference in DNA sequence was associated with power ability referred to the R577X polymorphism
of the ACTN3 gene, where translation (C > T) at nucleotide position 1747 in the ACTN3 coding sequence converts an arginine (R) to a stop
codon (X) at residue 577. In the present study, DNA polymorphism derived from the ACTN3 gene was studied in Polish rowers to examine the
hypothesis that the ACTN3 genotype is associated with athletic performance. The study involved 80 male Polish rowers of a nationally
competitive standard and 204 unrelated volunteers for controls. Genotype distribution among the whole group of athletes (53.8% RR, 38.8% RX,
7.4 XX% DD) was significantly different to that among controls (36.3% RR, 46.1% RX, 17.6%; p ¼ 0.01). When only elite rowers were
considered, p value for genotype distribution (56.8% RR, 37.8% RX, 5.4% XX) was 0.03. The genotype distribution among nonelite rowers
(52.2% RR, 39.1% RX, 8.7% XX) was not significantly different to that among controls ( p ¼ 0.09). A significant excess of the 577R allele was
noted in the whole cohort of rowers (73.11%, p ¼ 0.002). This trend was similar when comparing with the controls (59.3%) the allele frequency
in elite rowers (75.7%, p ¼ 0.007) and nonelite rowers (71.7%, p ¼ 0.026). In conclusion, our results are contrary to the hypothesis that the
ACTN3 577X allele may have some beneficial effect on endurance performance in rowing. On the contrary, the ACTN3 RX or RR genotypes
seem to be a requirement for being an elite rower, therefore, identification of ACTN3 polymorphism as a genetic marker for rowing talent should
be interpreted with great caution.
Copyright  2012, The Society of Chinese Scholars on Exercise Physiology and Fitness. Published by Elsevier (Singapore) Pte Ltd. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The response of the human body to physical training is
highly variable among individuals, and many studies have
indicated that this response may be strongly influenced by
genetic variation.1 The first evidence that a mononucleotide
difference in DNA sequence was associated with power ability
referred to the R577X polymorphism of the ACTN3 gene,2
where the translation (C > T) at nucleotide position 1747 in
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versions of the ACTN3 gene, both of which are common in the
general population: the 577R allele is the normal, functional
version of the gene, whereas the 577X allele contains
a sequence change that completely prevents the production of
functional a-actinin-3 protein.4 The complete deficiency of the
a-actinin-3 in 577X homozygotes does not result in a disease
phenotype,4,5 proven by the fact that > 1 billion people
worldwide have XX genotype.6
The a-actinins are a family of actin-binding proteins related
to dystrophin.2,7 In skeletal muscle, a-actinin proteins are an
important structural component of the Z disc, where they
anchor actin thin filaments, helping to maintain the myofi-
brillar array.8,9 Moreover, a-actinins, interacting with many
muscle proteins, carry out some signaling and metaboliccise Physiology and Fitness. Published by Elsevier (Singapore) Pte Ltd. This is an open
/4.0/).
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predominant fast fiber isoform in humans/human muscle.
Furthermore, it is suggested that a-actinin-3 may promote the
formation of fast-twitch fibers10 or alter glucose metabolism in
response to training.2 Additionally, a-actinin-3 may be
evolutionarily optimized for the minimization of damage
caused by eccentric muscle contraction.2
Two sarcomeric a-actinin isoforms exist in humans: a-
actinin-2 (which is expressed in all types of muscle fibers) and
a-actinin-3 (which is expressed almost exclusively in fast,
glycolytic type II fibers).3,7 Although it is likely that a-actinin-
3 protein has many similar roles to a-actinin-2,3,7 some
authors suggest that the ACTN3 gene has been maintained in
the genome because of functions independent of ACTN2.2
The 577R allele and 577RR genotype of the ACTN3 gene
are associated with top-level, power-orientated athletic
performance in a wide variety of ethnic groups.2,11e16 Addi-
tionally, there is a positive association between the presence of
the R allele and the capacity to perform high-power muscle
contractions.17,18 Furthermore, Vincent et al.10 have shown
that the percentage surface and number of type IIx (fast-twitch
glycolytic) fibers was greater in the RR than the XX genotype
of young healthy men.
However, the role of the 577X allele and 577XX genotype
in athletic performance has not yet been sufficiently clari-
fied.19 Some studies have reported that the loss of a-actinin-3
expression in a knockout mouse model results in a shift in fast
muscle metabolism toward the more efficient aerobic pathway
and an increase in intrinsic endurance performance.20,21 It may
be proof for the Yang et al2 hypothesis, that the total deficiency
of the a-actinin-3 protein may confer some beneficial effect on
endurance performance. This hypothesis seems to be sup-
ported by the fact that the XX ACTN3 genotype occurs at
higher frequency in some groups of elite endurance
athletes.2,11,19 In contrast to the studies mentioned above, there
has been recent evidence that the XX ACTN3 genotype is not
associated with endurance performance.2,23e25
The aims of the present study were to perform preliminary
analysis of the possible importance of the ACTN3 gene poly-
morphisms in elite Polish rowers and sedentary individuals,
and represent the possible relationships between genotype and
physical performance.
Materials and methodsEthics committeeThe Pomeranian Medical University Ethics Committee
approved the study and written informed consent was obtained
from each participant.Participants and controlsEighty male Polish rowers of a nationally competitive
standard were recruited for this study. Thirty-seven of them
were elite rowers (aged 28  4.1 years); national representa-
tives with no less than 10 years experience participating in thesport. Eleven of them were European Championship medal-
ists, seven were World Championship medalists, and 14 were
Olympic medalists. The second group of recruited athletes
(n ¼ 46) were nonelite rowers consisting of Polish men (aged
23  3.1 years) who had competed regionally. To avoid
selection bias, various methods were used to obtain the
samples: targeting national rowing teams, and information
provided by national coaching staff and athletes attending
training camps.
The controls were 204 volunteers (healthy, sedentary,
unrelated, male students of University of Szczecin, aged
22  2.6 years). The athletes and controls were all Caucasian
to reduce the likelihood of racial gene skew and to overcome
any potential problems of population stratification.GenotypingThe buccal cells donated by the participants were collected
in Resuspension Solution (Sigma, Germany) with use of Sterile
Foam Tipped Applicators (Puritan, USA). DNA was extracted
from the buccal cells using GenElute Mammalian Genomic
DNA Miniprep Kit (Sigma) according to the manufacturer’s
protocol. The 290-bp fragment of exon 15 of the ACTN3 gene
was amplified by polymerase chain reaction (PCR) using the
forward primer CTGTTGCCTGTGGTAAGTGGG and the
reverse primer TGGTCACA GTATGCAGGAGGG. The PCR
reaction mix contained 1 mL (30e50 ng) DNA, 0.2 mL primers
(10 pmol/mL), and 0.1 mL Taq Polymerase (5 U/mL). PCR was
performed for 35 cycles (30 seconds each of denaturation at
94 C, annealing at 68 C, and extension at 72 C). The
amplified PCR fragments were subsequently digested with
DdeI endonuclease (Fermentas, Lithuania), and the alleles
577R and 577X were distinguished by the presence (577X) or
absence (577R) of a DdeI restriction site. Digestion of PCR
products of the 577X allele yielded bands of 108 bp, 97 bp and
86 bp, whereas digestion of PCR products of the 577R allele
yielded bands of 205 bp and 86 bp. Digested products were then
electrophoresed on three agarose gels stained with ethidium
bromide.Statistical analysisGenotype distribution and allele frequencies between
groups of athletes and controls were compared and signifi-
cance was assessed by c2 test using STATISTICA 8 statistical
package. P values < 0.05 were considered statistically
significant.
Results
ACTN3 genotype distribution among participants and
controls was in HardyeWeinberg equilibrium, making selec-
tion bias less likely. Genotype distribution of the control group
(36.3% RR, 46.1% RX, 17.6% XX) was similar to that re-
ported in previous studies of Caucasian populations.2,4,15,26
The distribution of the ACTN3 genotypes and alleles is
given in Table 1.
Table 1
Genotype and allele frequencies of ACTN3 R577X. These data are presented
as absolute and relative values (within parentheses). The p values correspond
to comparisons in genotype and allele frequencies between athlete groups and
controls.
Group n ACTN3 genotype p ACTN3 allele p
RR RX XX R X
All rowers 80 43
53.8%
31
38.8%
6
7.4%
0.01 117
73.11%
43
26.9%
0.002
Elite rowers 37 21
56.8%
14
37.8
2
5.4%
0.03 56
75.7%
18
24.3%
0.007
Nonelite rowers 46 24
52.2%
18
39.1%
4
8.7%
0.09 66
71.7%
26
28.3%
0.026
Controls 204 74
36.3%
94
46.1%
36
17.6%
d 242
59.3%
166
40.7%
d
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athletes (53.8% RR, 38.8% RX, 7.4 XX% DD) was signifi-
cantly different to that among controls (36.3% RR, 46.1% RX,
17.6%; p ¼ 0.01). When only elite rowers were considered,
the p value for genotype distribution (56.8% RR, 37.8% RX,
5.4% XX) was 0.03. The genotype distribution among the
nonelite rowers (52.2% RR, 39.1% RX, 8.7% XX) was not
significantly different to that among the controls ( p ¼ 0.09).
A significant excess of the 577R allele was noted in the
whole cohort of rowers (73.11%, p ¼ 0.002). This trend was
similar when comparing with the controls (59.3%) the allele
frequency in elite (75.7%, p ¼ 0.007) and nonelite (71.7%,
p ¼ 0.026) rowers.
The genotype distribution among the elite and nonelite
rowers was not significantly different ( p ¼ 0.82), similar to
allele frequency ( p ¼ 0.56).
It should be noted that all of the Olympic and World and
European Championship medalists in the study sample had at
least one R allele for ACTN3. There were only two World
Championship participants with XX genotype among the elite
rowers.
Discussion
ACTN3 gene is the first structural skeletal-muscle gene for
which an association between fitness and performance
phenotypes has been demonstrated.7 Evidence for strong
ACTN3 gene influences on elite athletic performance was first
reported by Yang et al2 in 2003.
The possible mechanism underlying the association of the
ACTN3 R577X polymorphism with athletic performance has
been discussed in detail by MacArthur and North6 and Mac-
Arthur et al.20 A few reports have shown that the ACTN3 RR
and RX genotypes are associated with predisposition to power
sports and positively correlated with elite strength/power
athletes.2,11e16
By contrast, there is the hypothesis that the total deficiency
of the a-actinin-3 protein may confer some beneficial effect on
endurance performance.2 This hypothesis was taken into
consideration by Norman et al,27 who suggested that individ-
uals with no ACTN3 expression may be predisposed todeveloping a higher percentage of type I muscle fibers,
benefiting endurance performance. Additionally, Chan et al28
have reported that the absence of a-actinin-3, as marked by
the X allele, promotes a shift in metabolic pathways favoring
aerobic performance in a knockout mouse model. Further-
more, the XX ACTN3 genotype occurs at higher frequency in
some groups of elite endurance athletes compared to
controls.2,11,19
Our results are contrary to the conclusions listed above. The
ACTN3 577 XX genotype in all rowers was lower compared to
the controls ( p ¼ 0.01). Only six of the 80 (7.5%) investigated
rowers had the XX genotype. In the control group, this
percentage was 17.65% (36 of 204 rowers).
Our results show that the R allele of the ACTN3 gene is
advantageous in the case of top-level rowers, in whom
endurance and excellent isokinetic strength and power are
required.29 It should be noted that all of the Olympic and
World and European Championship medalists in the study
sample had at least one R allele for ACTN3, and 21 of 37
(56.8%) of all top-level rowers were RR homozygotes.
Several studies have confirmed our findings, in which the
XX ACTN3 genotype was also not found to be associated with
endurance performance.22,24e26,30 In addition, 99% of Kenyan
elite endurance athletes23 and 75% of Greek international-
level athletes in endurance-based sports12 had at least one R
allele of the ACTN3 gene. The same conclusion has been
reached by Ahmetov et al,26 who have explained the high
percentage of R allele (and its importance) in endurance-
orientated athletes by the fact that, in most endurance events
in which the races begin with a mass start, the strategies to win
include covering the distance with the top participants of the
race for as long as possible, and turning the long-distance fight
into an exhausted sprint for the finish. This hypothesis is
supported by Lucia et al,31 who have supposed the very high
speeds and near maximal intensities at which top endurance-
orientated athletes currently perform during the competi-
tively critical phases of the races in which they must
effectively sprint for short distances, probably requires the
ability to recruit type II fibers, that is, expressing a-actinin-3
protein. Regarding the rowers, these assumptions seem to be
confirmed by the “physiological pattern of the rowing
competition” proposed by Hagermen,32 and the fact reported
by Ahmetov et al26 that male rowers with the ACTN3 577XX
genotype showed the slowest rowing time compared to the
577RR homozygotes, with a time of approximately 1 minute.
It is well established that rowers should exhibit excellent
isokinetic strength and power.29 They utilize a unique physi-
ological pattern of race pacing; they begin exertion with
a vigorous sprint that places excessive demands on anaerobic
metabolism, followed by a severely high aerobic steady-state
and a fast finish.29
It is worth observing the lack of significant differences in
genotype distribution and allele frequency between elite and
nonelite rowers. This fact may suggest that the ACTN3 R577X
polymorphism plays an important role in rowing (regardless of
the athlete’s status) and may be one of the key factors in long-
term participation in the sport in general.
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allele frequency on rowing. Regarding this hypothesis, there is
the question of how to explain why two elite rowers (Europe
Championships medalists) were 577XX homozygotes. Similar
observations have been made regarding power-orientated
sports such as the long jump31 or hammer throwing.15 In
this case, there is a hypothesis that a-actinin-3 deficiency in
men may be compensated by androgen hormones.14 It is also
worth remembering that, like other sport phenotypes, endur-
ance performance seems to be multifactorial and an oligogenic
trait (e.g., a phenotypic trait produced by two or more genes
working together).19 Norman et al27 have suspected that the
lack of a-actinin-3 in the XX genotype does not compromise
muscle function, suggesting that the other isoform, a-actinin-
2, may compensate for the lack of a-actinin-3.
In conclusion, our results are contrary to the hypothesis that
ACTN3 577XX allele may confer some beneficial effect on
endurance performance in rowing. On the contrary, the ACTN3
RX or RR genotypes seem to be a requirement for being an
elite rower, however, the identification of ACTN3 poly-
morphism as a genetic marker for rowing talent should be
interpreted with great caution.References
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